Aspirin‐targeted PD‐L1 in Lung Cancer Growth Inhibition

Thoracic Cancer - Australia
doi 10.1111/1759-7714.13433
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

PD-L1 Assessment for Targeted Therapy Testing in Cancer

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2017English

PD-L1 Gene Expression in Japanese Lung Cancer Patients

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2012English

Design of PD-L1 Inhibitors for Lung Cancer

Bioinformation
2019English

Exosomal PD-L1 Promotes Tumor Growth Through Immune Escape in Non-Small Cell Lung Cancer

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2019English

PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2014English

Inhibition of COX-2 and EGFR by Melafolone Improves Anti-Pd-1 Therapy Through Vascular Normalization and PD-L1 Downregulation in Lung Cancer

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

6P Expression of PD-L1 in Lung Cancer Cells Regulates Treg Cell Differentiation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-82 Neutrophil-To-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy